nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—Topoisomerase Inhibitors—Etoposide—brain cancer	0.398	1	CiPCiCtD
Doxorubicin—bone cancer—brain cancer	0.154	0.577	CtDrD
Doxorubicin—peripheral nervous system neoplasm—brain cancer	0.113	0.423	CtDrD
Doxorubicin—XDH—Procarbazine—brain cancer	0.0529	0.249	CbGbCtD
Doxorubicin—CYP1B1—Procarbazine—brain cancer	0.0352	0.166	CbGbCtD
Doxorubicin—NQO1—Carboplatin—brain cancer	0.0248	0.117	CbGbCtD
Doxorubicin—ABCC6—Etoposide—brain cancer	0.0174	0.082	CbGbCtD
Doxorubicin—ABCC10—Etoposide—brain cancer	0.0133	0.0626	CbGbCtD
Doxorubicin—XDH—Carboplatin—brain cancer	0.013	0.061	CbGbCtD
Doxorubicin—TOP2A—Etoposide—brain cancer	0.00927	0.0436	CbGbCtD
Doxorubicin—ABCC3—Etoposide—brain cancer	0.00836	0.0394	CbGbCtD
Doxorubicin—ABCC1—Etoposide—brain cancer	0.00514	0.0242	CbGbCtD
Doxorubicin—CYP2D6—Lomustine—brain cancer	0.00483	0.0228	CbGbCtD
Doxorubicin—ABCC2—Carboplatin—brain cancer	0.00453	0.0213	CbGbCtD
Doxorubicin—ABCG2—Carboplatin—brain cancer	0.00409	0.0193	CbGbCtD
Doxorubicin—ABCC2—Etoposide—brain cancer	0.0038	0.0179	CbGbCtD
Doxorubicin—CYP2D6—Hydroxyurea—brain cancer	0.00366	0.0172	CbGbCtD
Doxorubicin—CYP3A4—Temozolomide—brain cancer	0.00361	0.017	CbGbCtD
Doxorubicin—ABCG2—Etoposide—brain cancer	0.00344	0.0162	CbGbCtD
Doxorubicin—CYP3A4—Lomustine—brain cancer	0.00307	0.0145	CbGbCtD
Doxorubicin—ABCB1—Etoposide—brain cancer	0.00124	0.00584	CbGbCtD
Doxorubicin—NOS3—vein—brain cancer	0.00106	0.0349	CbGeAlD
Doxorubicin—ABCB8—ganglion—brain cancer	0.000986	0.0325	CbGeAlD
Doxorubicin—CYP3A4—Etoposide—brain cancer	0.000742	0.0035	CbGbCtD
Doxorubicin—Idarubicin—CYP2C9—brain cancer	0.000666	1	CrCbGaD
Doxorubicin—NOS1—ganglion—brain cancer	0.000555	0.0183	CbGeAlD
Doxorubicin—NDUFS3—ganglion—brain cancer	0.000545	0.018	CbGeAlD
Doxorubicin—NOS1—endothelium—brain cancer	0.000479	0.0158	CbGeAlD
Doxorubicin—NOS1—blood vessel—brain cancer	0.000442	0.0146	CbGeAlD
Doxorubicin—NOS1—hindbrain—brain cancer	0.000421	0.0139	CbGeAlD
Doxorubicin—NDUFS3—hindbrain—brain cancer	0.000413	0.0136	CbGeAlD
Doxorubicin—SLC22A16—gonad—brain cancer	0.000408	0.0135	CbGeAlD
Doxorubicin—ABCB8—telencephalon—brain cancer	0.00038	0.0126	CbGeAlD
Doxorubicin—NOS3—endothelium—brain cancer	0.000364	0.012	CbGeAlD
Doxorubicin—NOS3—blood vessel—brain cancer	0.000336	0.0111	CbGeAlD
Doxorubicin—NQO1—ganglion—brain cancer	0.000321	0.0106	CbGeAlD
Doxorubicin—ABCB8—gonad—brain cancer	0.000317	0.0105	CbGeAlD
Doxorubicin—ABCC6—Podofilox—Etoposide—brain cancer	0.000317	0.277	CbGdCrCtD
Doxorubicin—ABCB8—pituitary gland—brain cancer	0.00031	0.0102	CbGeAlD
Doxorubicin—SLC22A16—endocrine gland—brain cancer	0.000309	0.0102	CbGeAlD
Doxorubicin—CBR3—Teniposide—Etoposide—brain cancer	0.000285	0.249	CbGdCrCtD
Doxorubicin—AKR1A1—telencephalon—brain cancer	0.000283	0.00933	CbGeAlD
Doxorubicin—AKR1C3—Podofilox—Etoposide—brain cancer	0.000277	0.242	CbGdCrCtD
Doxorubicin—NDUFS7—telencephalon—brain cancer	0.000257	0.00848	CbGeAlD
Doxorubicin—NOS1—brainstem—brain cancer	0.000241	0.00797	CbGeAlD
Doxorubicin—ABCB8—endocrine gland—brain cancer	0.00024	0.00792	CbGeAlD
Doxorubicin—NDUFS3—brainstem—brain cancer	0.000237	0.00782	CbGeAlD
Doxorubicin—ABCB8—head—brain cancer	0.000237	0.00781	CbGeAlD
Doxorubicin—AKR1A1—gonad—brain cancer	0.000236	0.00778	CbGeAlD
Doxorubicin—AKR1A1—pituitary gland—brain cancer	0.00023	0.00759	CbGeAlD
Doxorubicin—CBR3—head—brain cancer	0.000228	0.00752	CbGeAlD
Doxorubicin—AKR1A1—medulla oblongata—brain cancer	0.000222	0.00733	CbGeAlD
Doxorubicin—ABCB8—central nervous system—brain cancer	0.000216	0.00713	CbGeAlD
Doxorubicin—NOS1—telencephalon—brain cancer	0.000214	0.00707	CbGeAlD
Doxorubicin—NDUFS2—telencephalon—brain cancer	0.000213	0.00702	CbGeAlD
Doxorubicin—ABCB8—cerebellum—brain cancer	0.000211	0.00697	CbGeAlD
Doxorubicin—NDUFS3—telencephalon—brain cancer	0.00021	0.00694	CbGeAlD
Doxorubicin—CBR3—central nervous system—brain cancer	0.000208	0.00687	CbGeAlD
Doxorubicin—CBR3—cerebellum—brain cancer	0.000203	0.00671	CbGeAlD
Doxorubicin—AKR1A1—midbrain—brain cancer	0.000203	0.0067	CbGeAlD
Doxorubicin—DHCR7—telencephalon—brain cancer	0.0002	0.00659	CbGeAlD
Doxorubicin—AURKA—gonad—brain cancer	0.000199	0.00658	CbGeAlD
Doxorubicin—AKR1A1—spinal cord—brain cancer	0.000198	0.00654	CbGeAlD
Doxorubicin—AURKA—pituitary gland—brain cancer	0.000195	0.00642	CbGeAlD
Doxorubicin—NDUFS7—midbrain—brain cancer	0.000185	0.00609	CbGeAlD
Doxorubicin—YWHAG—telencephalon—brain cancer	0.000183	0.00605	CbGeAlD
Doxorubicin—NDUFS7—spinal cord—brain cancer	0.00018	0.00594	CbGeAlD
Doxorubicin—NOS1—gonad—brain cancer	0.000179	0.0059	CbGeAlD
Doxorubicin—AKR1A1—endocrine gland—brain cancer	0.000178	0.00588	CbGeAlD
Doxorubicin—NDUFS2—gonad—brain cancer	0.000178	0.00586	CbGeAlD
Doxorubicin—AKR1A1—head—brain cancer	0.000176	0.00581	CbGeAlD
Doxorubicin—NDUFS3—gonad—brain cancer	0.000176	0.00579	CbGeAlD
Doxorubicin—NDUFS2—pituitary gland—brain cancer	0.000173	0.00572	CbGeAlD
Doxorubicin—ABCB8—brain—brain cancer	0.000172	0.00566	CbGeAlD
Doxorubicin—NDUFS3—pituitary gland—brain cancer	0.000171	0.00565	CbGeAlD
Doxorubicin—NOS1—medulla oblongata—brain cancer	0.000168	0.00555	CbGeAlD
Doxorubicin—NDUFS2—medulla oblongata—brain cancer	0.000167	0.00552	CbGeAlD
Doxorubicin—DHCR7—gonad—brain cancer	0.000167	0.0055	CbGeAlD
Doxorubicin—RALBP1—telencephalon—brain cancer	0.000166	0.00546	CbGeAlD
Doxorubicin—NDUFS3—medulla oblongata—brain cancer	0.000165	0.00545	CbGeAlD
Doxorubicin—CBR3—brain—brain cancer	0.000165	0.00545	CbGeAlD
Doxorubicin—NOS3—telencephalon—brain cancer	0.000163	0.00537	CbGeAlD
Doxorubicin—DHCR7—pituitary gland—brain cancer	0.000163	0.00537	CbGeAlD
Doxorubicin—NDUFS7—endocrine gland—brain cancer	0.000162	0.00535	CbGeAlD
Doxorubicin—AKR1A1—central nervous system—brain cancer	0.000161	0.0053	CbGeAlD
Doxorubicin—NDUFS7—head—brain cancer	0.00016	0.00528	CbGeAlD
Doxorubicin—AKR1A1—cerebellum—brain cancer	0.000157	0.00518	CbGeAlD
Doxorubicin—DHCR7—medulla oblongata—brain cancer	0.000157	0.00518	CbGeAlD
Doxorubicin—CBR1—telencephalon—brain cancer	0.000155	0.0051	CbGeAlD
Doxorubicin—YWHAG—gonad—brain cancer	0.000153	0.00505	CbGeAlD
Doxorubicin—NDUFS2—midbrain—brain cancer	0.000153	0.00504	CbGeAlD
Doxorubicin—NDUFS3—midbrain—brain cancer	0.000151	0.00498	CbGeAlD
Doxorubicin—AURKA—endocrine gland—brain cancer	0.000151	0.00497	CbGeAlD
Doxorubicin—AURKA—Teniposide—Etoposide—brain cancer	0.00015	0.131	CbGdCrCtD
Doxorubicin—NOS1—spinal cord—brain cancer	0.00015	0.00495	CbGeAlD
Doxorubicin—YWHAG—pituitary gland—brain cancer	0.000149	0.00493	CbGeAlD
Doxorubicin—NDUFS2—spinal cord—brain cancer	0.000149	0.00492	CbGeAlD
Doxorubicin—AURKA—head—brain cancer	0.000149	0.00491	CbGeAlD
Doxorubicin—NDUFS3—spinal cord—brain cancer	0.000147	0.00486	CbGeAlD
Doxorubicin—NDUFS7—central nervous system—brain cancer	0.000146	0.00482	CbGeAlD
Doxorubicin—YWHAG—medulla oblongata—brain cancer	0.000144	0.00475	CbGeAlD
Doxorubicin—DHCR7—midbrain—brain cancer	0.000144	0.00473	CbGeAlD
Doxorubicin—NDUFS7—cerebellum—brain cancer	0.000143	0.00471	CbGeAlD
Doxorubicin—DHCR7—spinal cord—brain cancer	0.00014	0.00462	CbGeAlD
Doxorubicin—AURKA—central nervous system—brain cancer	0.000136	0.00448	CbGeAlD
Doxorubicin—NOS1—endocrine gland—brain cancer	0.000135	0.00446	CbGeAlD
Doxorubicin—RALBP1—pituitary gland—brain cancer	0.000135	0.00445	CbGeAlD
Doxorubicin—NDUFS2—endocrine gland—brain cancer	0.000134	0.00443	CbGeAlD
Doxorubicin—NOS1—head—brain cancer	0.000133	0.0044	CbGeAlD
Doxorubicin—NDUFS3—endocrine gland—brain cancer	0.000133	0.00438	CbGeAlD
Doxorubicin—NDUFS2—head—brain cancer	0.000133	0.00437	CbGeAlD
Doxorubicin—YWHAG—midbrain—brain cancer	0.000132	0.00434	CbGeAlD
Doxorubicin—NDUFS3—head—brain cancer	0.000131	0.00432	CbGeAlD
Doxorubicin—RALBP1—medulla oblongata—brain cancer	0.00013	0.00429	CbGeAlD
Doxorubicin—CBR1—gonad—brain cancer	0.000129	0.00426	CbGeAlD
Doxorubicin—YWHAG—spinal cord—brain cancer	0.000128	0.00424	CbGeAlD
Doxorubicin—AKR1A1—brain—brain cancer	0.000128	0.00421	CbGeAlD
Doxorubicin—DHCR7—endocrine gland—brain cancer	0.000126	0.00416	CbGeAlD
Doxorubicin—CBR1—pituitary gland—brain cancer	0.000126	0.00415	CbGeAlD
Doxorubicin—DHCR7—head—brain cancer	0.000124	0.00411	CbGeAlD
Doxorubicin—AKR1C3—pituitary gland—brain cancer	0.000124	0.0041	CbGeAlD
Doxorubicin—NQO1—telencephalon—brain cancer	0.000124	0.00409	CbGeAlD
Doxorubicin—ABCC6—endocrine gland—brain cancer	0.000123	0.00405	CbGeAlD
Doxorubicin—NOS1—central nervous system—brain cancer	0.000122	0.00402	CbGeAlD
Doxorubicin—CBR1—medulla oblongata—brain cancer	0.000121	0.00401	CbGeAlD
Doxorubicin—ABCC6—head—brain cancer	0.000121	0.004	CbGeAlD
Doxorubicin—NDUFS2—central nervous system—brain cancer	0.000121	0.00399	CbGeAlD
Doxorubicin—AKR1C3—medulla oblongata—brain cancer	0.00012	0.00396	CbGeAlD
Doxorubicin—NDUFS3—central nervous system—brain cancer	0.00012	0.00394	CbGeAlD
Doxorubicin—NOS1—cerebellum—brain cancer	0.000119	0.00393	CbGeAlD
Doxorubicin—RALBP1—midbrain—brain cancer	0.000119	0.00392	CbGeAlD
Doxorubicin—NDUFS2—cerebellum—brain cancer	0.000118	0.0039	CbGeAlD
Doxorubicin—NDUFS3—cerebellum—brain cancer	0.000117	0.00385	CbGeAlD
Doxorubicin—RALBP1—spinal cord—brain cancer	0.000116	0.00383	CbGeAlD
Doxorubicin—NDUFS7—brain—brain cancer	0.000116	0.00383	CbGeAlD
Doxorubicin—YWHAG—endocrine gland—brain cancer	0.000116	0.00382	CbGeAlD
Doxorubicin—YWHAG—head—brain cancer	0.000114	0.00377	CbGeAlD
Doxorubicin—DHCR7—central nervous system—brain cancer	0.000114	0.00375	CbGeAlD
Doxorubicin—POR—pituitary gland—brain cancer	0.000114	0.00374	CbGeAlD
Doxorubicin—XDH—endocrine gland—brain cancer	0.000113	0.00372	CbGeAlD
Doxorubicin—DHCR7—cerebellum—brain cancer	0.000111	0.00366	CbGeAlD
Doxorubicin—CBR1—midbrain—brain cancer	0.000111	0.00366	CbGeAlD
Doxorubicin—ABCC10—telencephalon—brain cancer	0.000111	0.00365	CbGeAlD
Doxorubicin—ABCB11—endocrine gland—brain cancer	0.00011	0.00363	CbGeAlD
Doxorubicin—AKR1C3—midbrain—brain cancer	0.00011	0.00362	CbGeAlD
Doxorubicin—POR—medulla oblongata—brain cancer	0.00011	0.00361	CbGeAlD
Doxorubicin—CBR1—spinal cord—brain cancer	0.000108	0.00357	CbGeAlD
Doxorubicin—AURKA—brain—brain cancer	0.000108	0.00356	CbGeAlD
Doxorubicin—AKR1C3—spinal cord—brain cancer	0.000107	0.00353	CbGeAlD
Doxorubicin—RALBP1—endocrine gland—brain cancer	0.000104	0.00345	CbGeAlD
Doxorubicin—YWHAG—central nervous system—brain cancer	0.000104	0.00344	CbGeAlD
Doxorubicin—RALBP1—head—brain cancer	0.000103	0.0034	CbGeAlD
Doxorubicin—NOS3—endocrine gland—brain cancer	0.000103	0.00339	CbGeAlD
Doxorubicin—YWHAG—cerebellum—brain cancer	0.000102	0.00336	CbGeAlD
Doxorubicin—NOS3—head—brain cancer	0.000101	0.00335	CbGeAlD
Doxorubicin—NQO1—pituitary gland—brain cancer	0.000101	0.00333	CbGeAlD
Doxorubicin—POR—midbrain—brain cancer	0.0001	0.0033	CbGeAlD
Doxorubicin—POR—spinal cord—brain cancer	9.77e-05	0.00322	CbGeAlD
Doxorubicin—CBR1—endocrine gland—brain cancer	9.75e-05	0.00322	CbGeAlD
Doxorubicin—NQO1—medulla oblongata—brain cancer	9.73e-05	0.00321	CbGeAlD
Doxorubicin—NOS1—brain—brain cancer	9.67e-05	0.00319	CbGeAlD
Doxorubicin—CBR1—head—brain cancer	9.63e-05	0.00318	CbGeAlD
Doxorubicin—NDUFS2—brain—brain cancer	9.61e-05	0.00317	CbGeAlD
Doxorubicin—NDUFS3—brain—brain cancer	9.49e-05	0.00313	CbGeAlD
Doxorubicin—RALBP1—central nervous system—brain cancer	9.41e-05	0.0031	CbGeAlD
Doxorubicin—NOS3—central nervous system—brain cancer	9.26e-05	0.00305	CbGeAlD
Doxorubicin—ABCC10—gonad—brain cancer	9.23e-05	0.00305	CbGeAlD
Doxorubicin—RALBP1—cerebellum—brain cancer	9.2e-05	0.00303	CbGeAlD
Doxorubicin—DHCR7—brain—brain cancer	9.02e-05	0.00297	CbGeAlD
Doxorubicin—ABCC10—pituitary gland—brain cancer	9.01e-05	0.00297	CbGeAlD
Doxorubicin—NQO1—midbrain—brain cancer	8.89e-05	0.00293	CbGeAlD
Doxorubicin—POR—endocrine gland—brain cancer	8.79e-05	0.0029	CbGeAlD
Doxorubicin—CBR1—central nervous system—brain cancer	8.79e-05	0.0029	CbGeAlD
Doxorubicin—CYP2D6—hindbrain—brain cancer	8.73e-05	0.00288	CbGeAlD
Doxorubicin—CYP1B1—telencephalon—brain cancer	8.7e-05	0.00287	CbGeAlD
Doxorubicin—ABCC10—medulla oblongata—brain cancer	8.69e-05	0.00287	CbGeAlD
Doxorubicin—NQO1—spinal cord—brain cancer	8.68e-05	0.00286	CbGeAlD
Doxorubicin—CBR1—cerebellum—brain cancer	8.59e-05	0.00283	CbGeAlD
Doxorubicin—AKR1C3—cerebellum—brain cancer	8.48e-05	0.0028	CbGeAlD
Doxorubicin—YWHAG—brain—brain cancer	8.27e-05	0.00273	CbGeAlD
Doxorubicin—ABCC10—midbrain—brain cancer	7.94e-05	0.00262	CbGeAlD
Doxorubicin—ABCC1—telencephalon—brain cancer	7.82e-05	0.00258	CbGeAlD
Doxorubicin—NQO1—endocrine gland—brain cancer	7.81e-05	0.00258	CbGeAlD
Doxorubicin—ABCC10—spinal cord—brain cancer	7.75e-05	0.00256	CbGeAlD
Doxorubicin—POR—cerebellum—brain cancer	7.74e-05	0.00256	CbGeAlD
Doxorubicin—NQO1—head—brain cancer	7.71e-05	0.00254	CbGeAlD
Doxorubicin—RALBP1—brain—brain cancer	7.47e-05	0.00247	CbGeAlD
Doxorubicin—NOS3—brain—brain cancer	7.35e-05	0.00243	CbGeAlD
Doxorubicin—CYP1B1—gonad—brain cancer	7.26e-05	0.00239	CbGeAlD
Doxorubicin—CYP1B1—pituitary gland—brain cancer	7.08e-05	0.00234	CbGeAlD
Doxorubicin—NQO1—central nervous system—brain cancer	7.04e-05	0.00232	CbGeAlD
Doxorubicin—ABCC3—endocrine gland—brain cancer	7.01e-05	0.00231	CbGeAlD
Doxorubicin—ABCC10—endocrine gland—brain cancer	6.98e-05	0.0023	CbGeAlD
Doxorubicin—CBR1—brain—brain cancer	6.98e-05	0.0023	CbGeAlD
Doxorubicin—ABCC3—head—brain cancer	6.92e-05	0.00228	CbGeAlD
Doxorubicin—AKR1C3—brain—brain cancer	6.89e-05	0.00227	CbGeAlD
Doxorubicin—NQO1—cerebellum—brain cancer	6.88e-05	0.00227	CbGeAlD
Doxorubicin—ABCB1—blood vessel—brain cancer	6.58e-05	0.00217	CbGeAlD
Doxorubicin—ABCG2—telencephalon—brain cancer	6.48e-05	0.00214	CbGeAlD
Doxorubicin—ABCC1—pituitary gland—brain cancer	6.37e-05	0.0021	CbGeAlD
Doxorubicin—ABCC3—central nervous system—brain cancer	6.32e-05	0.00208	CbGeAlD
Doxorubicin—POR—brain—brain cancer	6.29e-05	0.00208	CbGeAlD
Doxorubicin—ABCC10—cerebellum—brain cancer	6.15e-05	0.00203	CbGeAlD
Doxorubicin—TOP2A—Teniposide—Etoposide—brain cancer	5.75e-05	0.0502	CbGdCrCtD
Doxorubicin—TOP2A—Podofilox—Etoposide—brain cancer	5.75e-05	0.0502	CbGdCrCtD
Doxorubicin—ABCC2—endocrine gland—brain cancer	5.6e-05	0.00185	CbGeAlD
Doxorubicin—NQO1—brain—brain cancer	5.59e-05	0.00184	CbGeAlD
Doxorubicin—CYP1B1—endocrine gland—brain cancer	5.49e-05	0.00181	CbGeAlD
Doxorubicin—CYP1B1—head—brain cancer	5.42e-05	0.00179	CbGeAlD
Doxorubicin—ABCG2—pituitary gland—brain cancer	5.27e-05	0.00174	CbGeAlD
Doxorubicin—ABCG2—medulla oblongata—brain cancer	5.09e-05	0.00168	CbGeAlD
Doxorubicin—ABCC3—brain—brain cancer	5.02e-05	0.00165	CbGeAlD
Doxorubicin—CYP2D6—brainstem—brain cancer	5e-05	0.00165	CbGeAlD
Doxorubicin—ABCC10—brain—brain cancer	4.99e-05	0.00165	CbGeAlD
Doxorubicin—CYP2B6—gonad—brain cancer	4.99e-05	0.00165	CbGeAlD
Doxorubicin—CYP1B1—central nervous system—brain cancer	4.94e-05	0.00163	CbGeAlD
Doxorubicin—CYP1B1—cerebellum—brain cancer	4.83e-05	0.00159	CbGeAlD
Doxorubicin—ABCG2—midbrain—brain cancer	4.65e-05	0.00153	CbGeAlD
Doxorubicin—ABCG2—spinal cord—brain cancer	4.54e-05	0.0015	CbGeAlD
Doxorubicin—CYP2D6—telencephalon—brain cancer	4.44e-05	0.00146	CbGeAlD
Doxorubicin—ABCC1—cerebellum—brain cancer	4.35e-05	0.00143	CbGeAlD
Doxorubicin—Anaemia—Hydroxyurea—brain cancer	4.05e-05	0.000698	CcSEcCtD
Doxorubicin—Hypoaesthesia—Carmustine—brain cancer	4.05e-05	0.000698	CcSEcCtD
Doxorubicin—Decreased appetite—Procarbazine—brain cancer	4.02e-05	0.000692	CcSEcCtD
Doxorubicin—Alanine aminotransferase increased—Etoposide—brain cancer	4.02e-05	0.000691	CcSEcCtD
Doxorubicin—Oedema peripheral—Carmustine—brain cancer	4.01e-05	0.000691	CcSEcCtD
Doxorubicin—Connective tissue disorder—Carmustine—brain cancer	4e-05	0.000689	CcSEcCtD
Doxorubicin—Fatigue—Procarbazine—brain cancer	3.99e-05	0.000686	CcSEcCtD
Doxorubicin—Haemoglobin—Temozolomide—brain cancer	3.96e-05	0.000681	CcSEcCtD
Doxorubicin—Malaise—Hydroxyurea—brain cancer	3.96e-05	0.000681	CcSEcCtD
Doxorubicin—Pain—Procarbazine—brain cancer	3.96e-05	0.000681	CcSEcCtD
Doxorubicin—Constipation—Procarbazine—brain cancer	3.96e-05	0.000681	CcSEcCtD
Doxorubicin—Haemorrhage—Temozolomide—brain cancer	3.94e-05	0.000678	CcSEcCtD
Doxorubicin—Hepatitis—Temozolomide—brain cancer	3.94e-05	0.000678	CcSEcCtD
Doxorubicin—Dysphagia—Etoposide—brain cancer	3.93e-05	0.000677	CcSEcCtD
Doxorubicin—Leukopenia—Hydroxyurea—brain cancer	3.93e-05	0.000676	CcSEcCtD
Doxorubicin—CYP1B1—brain—brain cancer	3.93e-05	0.00129	CbGeAlD
Doxorubicin—Visual impairment—Carmustine—brain cancer	3.92e-05	0.000676	CcSEcCtD
Doxorubicin—Hypoaesthesia—Temozolomide—brain cancer	3.92e-05	0.000674	CcSEcCtD
Doxorubicin—Pharyngitis—Temozolomide—brain cancer	3.91e-05	0.000672	CcSEcCtD
Doxorubicin—Urinary tract disorder—Temozolomide—brain cancer	3.89e-05	0.000669	CcSEcCtD
Doxorubicin—Oedema peripheral—Temozolomide—brain cancer	3.88e-05	0.000667	CcSEcCtD
Doxorubicin—Connective tissue disorder—Temozolomide—brain cancer	3.87e-05	0.000666	CcSEcCtD
Doxorubicin—Urethral disorder—Temozolomide—brain cancer	3.86e-05	0.000664	CcSEcCtD
Doxorubicin—Feeling abnormal—Procarbazine—brain cancer	3.81e-05	0.000656	CcSEcCtD
Doxorubicin—Eye disorder—Carmustine—brain cancer	3.81e-05	0.000655	CcSEcCtD
Doxorubicin—Convulsion—Hydroxyurea—brain cancer	3.8e-05	0.000654	CcSEcCtD
Doxorubicin—Visual impairment—Temozolomide—brain cancer	3.79e-05	0.000653	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Procarbazine—brain cancer	3.78e-05	0.000651	CcSEcCtD
Doxorubicin—Flushing—Carmustine—brain cancer	3.78e-05	0.000651	CcSEcCtD
Doxorubicin—CYP2B6—endocrine gland—brain cancer	3.77e-05	0.00124	CbGeAlD
Doxorubicin—Pancytopenia—Etoposide—brain cancer	3.74e-05	0.000643	CcSEcCtD
Doxorubicin—Erythema multiforme—Temozolomide—brain cancer	3.72e-05	0.000641	CcSEcCtD
Doxorubicin—CYP2B6—head—brain cancer	3.72e-05	0.00123	CbGeAlD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	3.71e-05	0.000638	CcSEcCtD
Doxorubicin—Discomfort—Hydroxyurea—brain cancer	3.69e-05	0.000635	CcSEcCtD
Doxorubicin—Neutropenia—Etoposide—brain cancer	3.68e-05	0.000633	CcSEcCtD
Doxorubicin—Eye disorder—Temozolomide—brain cancer	3.68e-05	0.000633	CcSEcCtD
Doxorubicin—Urticaria—Procarbazine—brain cancer	3.67e-05	0.000633	CcSEcCtD
Doxorubicin—Tinnitus—Temozolomide—brain cancer	3.67e-05	0.000632	CcSEcCtD
Doxorubicin—Abdominal pain—Procarbazine—brain cancer	3.66e-05	0.000629	CcSEcCtD
Doxorubicin—Body temperature increased—Procarbazine—brain cancer	3.66e-05	0.000629	CcSEcCtD
Doxorubicin—Flushing—Temozolomide—brain cancer	3.65e-05	0.000629	CcSEcCtD
Doxorubicin—Cardiac disorder—Temozolomide—brain cancer	3.65e-05	0.000629	CcSEcCtD
Doxorubicin—Arrhythmia—Carmustine—brain cancer	3.64e-05	0.000626	CcSEcCtD
Doxorubicin—Alopecia—Carmustine—brain cancer	3.6e-05	0.00062	CcSEcCtD
Doxorubicin—ABCG2—cerebellum—brain cancer	3.6e-05	0.00119	CbGeAlD
Doxorubicin—Oedema—Hydroxyurea—brain cancer	3.58e-05	0.000616	CcSEcCtD
Doxorubicin—Angiopathy—Temozolomide—brain cancer	3.57e-05	0.000615	CcSEcCtD
Doxorubicin—Mental disorder—Carmustine—brain cancer	3.57e-05	0.000614	CcSEcCtD
Doxorubicin—Infection—Hydroxyurea—brain cancer	3.56e-05	0.000612	CcSEcCtD
Doxorubicin—Immune system disorder—Temozolomide—brain cancer	3.56e-05	0.000612	CcSEcCtD
Doxorubicin—Mediastinal disorder—Temozolomide—brain cancer	3.55e-05	0.000611	CcSEcCtD
Doxorubicin—Malnutrition—Carmustine—brain cancer	3.55e-05	0.00061	CcSEcCtD
Doxorubicin—Erythema—Carmustine—brain cancer	3.55e-05	0.00061	CcSEcCtD
Doxorubicin—Chills—Temozolomide—brain cancer	3.53e-05	0.000608	CcSEcCtD
Doxorubicin—ABCC1—brain—brain cancer	3.53e-05	0.00116	CbGeAlD
Doxorubicin—Pneumonia—Etoposide—brain cancer	3.53e-05	0.000607	CcSEcCtD
Doxorubicin—Nervous system disorder—Hydroxyurea—brain cancer	3.51e-05	0.000604	CcSEcCtD
Doxorubicin—Infestation NOS—Etoposide—brain cancer	3.51e-05	0.000604	CcSEcCtD
Doxorubicin—Infestation—Etoposide—brain cancer	3.51e-05	0.000604	CcSEcCtD
Doxorubicin—Thrombocytopenia—Hydroxyurea—brain cancer	3.5e-05	0.000603	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Etoposide—brain cancer	3.48e-05	0.000599	CcSEcCtD
Doxorubicin—Alopecia—Temozolomide—brain cancer	3.48e-05	0.000599	CcSEcCtD
Doxorubicin—Skin disorder—Hydroxyurea—brain cancer	3.48e-05	0.000599	CcSEcCtD
Doxorubicin—Renal failure—Etoposide—brain cancer	3.45e-05	0.000594	CcSEcCtD
Doxorubicin—Mental disorder—Temozolomide—brain cancer	3.45e-05	0.000594	CcSEcCtD
Doxorubicin—Neuropathy peripheral—Etoposide—brain cancer	3.44e-05	0.000592	CcSEcCtD
Doxorubicin—Back pain—Carmustine—brain cancer	3.43e-05	0.00059	CcSEcCtD
Doxorubicin—Malnutrition—Temozolomide—brain cancer	3.43e-05	0.00059	CcSEcCtD
Doxorubicin—Erythema—Temozolomide—brain cancer	3.43e-05	0.00059	CcSEcCtD
Doxorubicin—Stomatitis—Etoposide—brain cancer	3.42e-05	0.000589	CcSEcCtD
Doxorubicin—Jaundice—Etoposide—brain cancer	3.42e-05	0.000589	CcSEcCtD
Doxorubicin—Anorexia—Hydroxyurea—brain cancer	3.41e-05	0.000587	CcSEcCtD
Doxorubicin—Hypersensitivity—Procarbazine—brain cancer	3.41e-05	0.000587	CcSEcCtD
Doxorubicin—CYP2B6—central nervous system—brain cancer	3.4e-05	0.00112	CbGeAlD
Doxorubicin—Dysgeusia—Temozolomide—brain cancer	3.36e-05	0.000578	CcSEcCtD
Doxorubicin—Vision blurred—Carmustine—brain cancer	3.34e-05	0.000575	CcSEcCtD
Doxorubicin—Asthenia—Procarbazine—brain cancer	3.32e-05	0.000571	CcSEcCtD
Doxorubicin—Hepatobiliary disease—Etoposide—brain cancer	3.32e-05	0.000571	CcSEcCtD
Doxorubicin—Back pain—Temozolomide—brain cancer	3.31e-05	0.000571	CcSEcCtD
Doxorubicin—Anaemia—Carmustine—brain cancer	3.28e-05	0.000564	CcSEcCtD
Doxorubicin—Agranulocytosis—Etoposide—brain cancer	3.27e-05	0.000564	CcSEcCtD
Doxorubicin—Pruritus—Procarbazine—brain cancer	3.27e-05	0.000563	CcSEcCtD
Doxorubicin—Agitation—Carmustine—brain cancer	3.26e-05	0.000561	CcSEcCtD
Doxorubicin—Vision blurred—Temozolomide—brain cancer	3.23e-05	0.000556	CcSEcCtD
Doxorubicin—ABCB1—telencephalon—brain cancer	3.19e-05	0.00105	CbGeAlD
Doxorubicin—Dyspnoea—Hydroxyurea—brain cancer	3.19e-05	0.000549	CcSEcCtD
Doxorubicin—Somnolence—Hydroxyurea—brain cancer	3.18e-05	0.000548	CcSEcCtD
Doxorubicin—Ill-defined disorder—Temozolomide—brain cancer	3.18e-05	0.000547	CcSEcCtD
Doxorubicin—Leukopenia—Carmustine—brain cancer	3.17e-05	0.000546	CcSEcCtD
Doxorubicin—Anaemia—Temozolomide—brain cancer	3.17e-05	0.000545	CcSEcCtD
Doxorubicin—Diarrhoea—Procarbazine—brain cancer	3.16e-05	0.000545	CcSEcCtD
Doxorubicin—Dyspepsia—Hydroxyurea—brain cancer	3.15e-05	0.000542	CcSEcCtD
Doxorubicin—Agitation—Temozolomide—brain cancer	3.15e-05	0.000542	CcSEcCtD
Doxorubicin—Hypoaesthesia—Etoposide—brain cancer	3.13e-05	0.000539	CcSEcCtD
Doxorubicin—Decreased appetite—Hydroxyurea—brain cancer	3.11e-05	0.000536	CcSEcCtD
Doxorubicin—Urinary tract disorder—Etoposide—brain cancer	3.11e-05	0.000535	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Hydroxyurea—brain cancer	3.09e-05	0.000532	CcSEcCtD
Doxorubicin—Malaise—Temozolomide—brain cancer	3.09e-05	0.000532	CcSEcCtD
Doxorubicin—Urethral disorder—Etoposide—brain cancer	3.09e-05	0.000531	CcSEcCtD
Doxorubicin—Fatigue—Hydroxyurea—brain cancer	3.09e-05	0.000531	CcSEcCtD
Doxorubicin—Vertigo—Temozolomide—brain cancer	3.08e-05	0.00053	CcSEcCtD
Doxorubicin—Convulsion—Carmustine—brain cancer	3.07e-05	0.000529	CcSEcCtD
Doxorubicin—Leukopenia—Temozolomide—brain cancer	3.07e-05	0.000528	CcSEcCtD
Doxorubicin—Hypertension—Carmustine—brain cancer	3.06e-05	0.000527	CcSEcCtD
Doxorubicin—Pain—Hydroxyurea—brain cancer	3.06e-05	0.000527	CcSEcCtD
Doxorubicin—Constipation—Hydroxyurea—brain cancer	3.06e-05	0.000527	CcSEcCtD
Doxorubicin—Dizziness—Procarbazine—brain cancer	3.06e-05	0.000527	CcSEcCtD
Doxorubicin—Palpitations—Temozolomide—brain cancer	3.03e-05	0.000521	CcSEcCtD
Doxorubicin—Chest pain—Carmustine—brain cancer	3.02e-05	0.00052	CcSEcCtD
Doxorubicin—Myalgia—Carmustine—brain cancer	3.02e-05	0.00052	CcSEcCtD
Doxorubicin—Anxiety—Carmustine—brain cancer	3.01e-05	0.000518	CcSEcCtD
Doxorubicin—Cough—Temozolomide—brain cancer	2.99e-05	0.000515	CcSEcCtD
Doxorubicin—Erythema multiforme—Etoposide—brain cancer	2.98e-05	0.000513	CcSEcCtD
Doxorubicin—Convulsion—Temozolomide—brain cancer	2.97e-05	0.000511	CcSEcCtD
Doxorubicin—Hypertension—Temozolomide—brain cancer	2.96e-05	0.000509	CcSEcCtD
Doxorubicin—Feeling abnormal—Hydroxyurea—brain cancer	2.95e-05	0.000508	CcSEcCtD
Doxorubicin—Eye disorder—Etoposide—brain cancer	2.94e-05	0.000507	CcSEcCtD
Doxorubicin—Vomiting—Procarbazine—brain cancer	2.94e-05	0.000506	CcSEcCtD
Doxorubicin—Flushing—Etoposide—brain cancer	2.92e-05	0.000503	CcSEcCtD
Doxorubicin—Cardiac disorder—Etoposide—brain cancer	2.92e-05	0.000503	CcSEcCtD
Doxorubicin—ABCG2—brain—brain cancer	2.92e-05	0.000964	CbGeAlD
Doxorubicin—Confusional state—Carmustine—brain cancer	2.92e-05	0.000502	CcSEcCtD
Doxorubicin—Myalgia—Temozolomide—brain cancer	2.92e-05	0.000502	CcSEcCtD
Doxorubicin—Arthralgia—Temozolomide—brain cancer	2.92e-05	0.000502	CcSEcCtD
Doxorubicin—Rash—Procarbazine—brain cancer	2.92e-05	0.000502	CcSEcCtD
Doxorubicin—Dermatitis—Procarbazine—brain cancer	2.91e-05	0.000502	CcSEcCtD
Doxorubicin—Anxiety—Temozolomide—brain cancer	2.91e-05	0.0005	CcSEcCtD
Doxorubicin—Headache—Procarbazine—brain cancer	2.9e-05	0.000499	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	2.9e-05	0.000499	CcSEcCtD
Doxorubicin—Oedema—Carmustine—brain cancer	2.89e-05	0.000498	CcSEcCtD
Doxorubicin—Discomfort—Temozolomide—brain cancer	2.88e-05	0.000496	CcSEcCtD
Doxorubicin—Infection—Carmustine—brain cancer	2.87e-05	0.000495	CcSEcCtD
Doxorubicin—Angiopathy—Etoposide—brain cancer	2.86e-05	0.000492	CcSEcCtD
Doxorubicin—Dry mouth—Temozolomide—brain cancer	2.85e-05	0.000491	CcSEcCtD
Doxorubicin—CYP3A4—endocrine gland—brain cancer	2.85e-05	0.000939	CbGeAlD
Doxorubicin—Immune system disorder—Etoposide—brain cancer	2.84e-05	0.00049	CcSEcCtD
Doxorubicin—Mediastinal disorder—Etoposide—brain cancer	2.84e-05	0.000489	CcSEcCtD
Doxorubicin—Thrombocytopenia—Carmustine—brain cancer	2.83e-05	0.000488	CcSEcCtD
Doxorubicin—Body temperature increased—Hydroxyurea—brain cancer	2.83e-05	0.000487	CcSEcCtD
Doxorubicin—Chills—Etoposide—brain cancer	2.83e-05	0.000486	CcSEcCtD
Doxorubicin—Tachycardia—Carmustine—brain cancer	2.82e-05	0.000486	CcSEcCtD
Doxorubicin—Confusional state—Temozolomide—brain cancer	2.82e-05	0.000485	CcSEcCtD
Doxorubicin—CYP2D6—endocrine gland—brain cancer	2.8e-05	0.000924	CbGeAlD
Doxorubicin—Oedema—Temozolomide—brain cancer	2.8e-05	0.000481	CcSEcCtD
Doxorubicin—Anaphylactic shock—Temozolomide—brain cancer	2.8e-05	0.000481	CcSEcCtD
Doxorubicin—Alopecia—Etoposide—brain cancer	2.78e-05	0.000479	CcSEcCtD
Doxorubicin—Infection—Temozolomide—brain cancer	2.78e-05	0.000478	CcSEcCtD
Doxorubicin—CYP2D6—head—brain cancer	2.76e-05	0.000912	CbGeAlD
Doxorubicin—Anorexia—Carmustine—brain cancer	2.76e-05	0.000475	CcSEcCtD
Doxorubicin—Nausea—Procarbazine—brain cancer	2.75e-05	0.000473	CcSEcCtD
Doxorubicin—Nervous system disorder—Temozolomide—brain cancer	2.74e-05	0.000472	CcSEcCtD
Doxorubicin—Thrombocytopenia—Temozolomide—brain cancer	2.74e-05	0.000471	CcSEcCtD
Doxorubicin—Skin disorder—Temozolomide—brain cancer	2.72e-05	0.000468	CcSEcCtD
Doxorubicin—Hypotension—Carmustine—brain cancer	2.7e-05	0.000465	CcSEcCtD
Doxorubicin—Hyperhidrosis—Temozolomide—brain cancer	2.7e-05	0.000465	CcSEcCtD
Doxorubicin—CYP2B6—brain—brain cancer	2.7e-05	0.00089	CbGeAlD
Doxorubicin—Dysgeusia—Etoposide—brain cancer	2.68e-05	0.000462	CcSEcCtD
Doxorubicin—ABCB1—gonad—brain cancer	2.67e-05	0.000879	CbGeAlD
Doxorubicin—Anorexia—Temozolomide—brain cancer	2.67e-05	0.000459	CcSEcCtD
Doxorubicin—Back pain—Etoposide—brain cancer	2.65e-05	0.000457	CcSEcCtD
Doxorubicin—Hypersensitivity—Hydroxyurea—brain cancer	2.64e-05	0.000454	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Carmustine—brain cancer	2.64e-05	0.000454	CcSEcCtD
Doxorubicin—Muscle spasms—Etoposide—brain cancer	2.64e-05	0.000454	CcSEcCtD
Doxorubicin—Insomnia—Carmustine—brain cancer	2.62e-05	0.000451	CcSEcCtD
Doxorubicin—ABCB1—pituitary gland—brain cancer	2.6e-05	0.000858	CbGeAlD
Doxorubicin—Paraesthesia—Carmustine—brain cancer	2.6e-05	0.000447	CcSEcCtD
Doxorubicin—Dyspnoea—Carmustine—brain cancer	2.58e-05	0.000444	CcSEcCtD
Doxorubicin—Somnolence—Carmustine—brain cancer	2.57e-05	0.000443	CcSEcCtD
Doxorubicin—Asthenia—Hydroxyurea—brain cancer	2.57e-05	0.000442	CcSEcCtD
Doxorubicin—CYP3A4—central nervous system—brain cancer	2.56e-05	0.000846	CbGeAlD
Doxorubicin—Musculoskeletal discomfort—Temozolomide—brain cancer	2.55e-05	0.000439	CcSEcCtD
Doxorubicin—Ill-defined disorder—Etoposide—brain cancer	2.54e-05	0.000438	CcSEcCtD
Doxorubicin—Anaemia—Etoposide—brain cancer	2.53e-05	0.000436	CcSEcCtD
Doxorubicin—Insomnia—Temozolomide—brain cancer	2.53e-05	0.000435	CcSEcCtD
Doxorubicin—CYP2D6—central nervous system—brain cancer	2.52e-05	0.000833	CbGeAlD
Doxorubicin—Decreased appetite—Carmustine—brain cancer	2.52e-05	0.000433	CcSEcCtD
Doxorubicin—Paraesthesia—Temozolomide—brain cancer	2.51e-05	0.000432	CcSEcCtD
Doxorubicin—ABCB1—medulla oblongata—brain cancer	2.51e-05	0.000828	CbGeAlD
Doxorubicin—Gastrointestinal disorder—Carmustine—brain cancer	2.5e-05	0.00043	CcSEcCtD
Doxorubicin—Dyspnoea—Temozolomide—brain cancer	2.49e-05	0.000429	CcSEcCtD
Doxorubicin—Somnolence—Temozolomide—brain cancer	2.49e-05	0.000428	CcSEcCtD
Doxorubicin—Constipation—Carmustine—brain cancer	2.47e-05	0.000426	CcSEcCtD
Doxorubicin—Pain—Carmustine—brain cancer	2.47e-05	0.000426	CcSEcCtD
Doxorubicin—Malaise—Etoposide—brain cancer	2.47e-05	0.000426	CcSEcCtD
Doxorubicin—CYP2D6—cerebellum—brain cancer	2.47e-05	0.000814	CbGeAlD
Doxorubicin—Vertigo—Etoposide—brain cancer	2.46e-05	0.000424	CcSEcCtD
Doxorubicin—Dyspepsia—Temozolomide—brain cancer	2.46e-05	0.000424	CcSEcCtD
Doxorubicin—Leukopenia—Etoposide—brain cancer	2.45e-05	0.000422	CcSEcCtD
Doxorubicin—Diarrhoea—Hydroxyurea—brain cancer	2.45e-05	0.000422	CcSEcCtD
Doxorubicin—Decreased appetite—Temozolomide—brain cancer	2.43e-05	0.000418	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Temozolomide—brain cancer	2.41e-05	0.000416	CcSEcCtD
Doxorubicin—Fatigue—Temozolomide—brain cancer	2.41e-05	0.000415	CcSEcCtD
Doxorubicin—Loss of consciousness—Etoposide—brain cancer	2.41e-05	0.000415	CcSEcCtD
Doxorubicin—Cough—Etoposide—brain cancer	2.39e-05	0.000412	CcSEcCtD
Doxorubicin—Constipation—Temozolomide—brain cancer	2.39e-05	0.000412	CcSEcCtD
Doxorubicin—Pain—Temozolomide—brain cancer	2.39e-05	0.000412	CcSEcCtD
Doxorubicin—Feeling abnormal—Carmustine—brain cancer	2.38e-05	0.00041	CcSEcCtD
Doxorubicin—Convulsion—Etoposide—brain cancer	2.38e-05	0.000409	CcSEcCtD
Doxorubicin—Hypertension—Etoposide—brain cancer	2.37e-05	0.000407	CcSEcCtD
Doxorubicin—Dizziness—Hydroxyurea—brain cancer	2.37e-05	0.000407	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Carmustine—brain cancer	2.37e-05	0.000407	CcSEcCtD
Doxorubicin—Chest pain—Etoposide—brain cancer	2.33e-05	0.000402	CcSEcCtD
Doxorubicin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	2.32e-05	0.000399	CcSEcCtD
Doxorubicin—Discomfort—Etoposide—brain cancer	2.31e-05	0.000397	CcSEcCtD
Doxorubicin—Feeling abnormal—Temozolomide—brain cancer	2.3e-05	0.000397	CcSEcCtD
Doxorubicin—ABCB1—midbrain—brain cancer	2.29e-05	0.000757	CbGeAlD
Doxorubicin—Body temperature increased—Carmustine—brain cancer	2.29e-05	0.000394	CcSEcCtD
Doxorubicin—Abdominal pain—Carmustine—brain cancer	2.29e-05	0.000394	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Temozolomide—brain cancer	2.29e-05	0.000394	CcSEcCtD
Doxorubicin—Vomiting—Hydroxyurea—brain cancer	2.28e-05	0.000392	CcSEcCtD
Doxorubicin—Rash—Hydroxyurea—brain cancer	2.26e-05	0.000389	CcSEcCtD
Doxorubicin—Confusional state—Etoposide—brain cancer	2.26e-05	0.000388	CcSEcCtD
Doxorubicin—Dermatitis—Hydroxyurea—brain cancer	2.25e-05	0.000388	CcSEcCtD
Doxorubicin—Headache—Hydroxyurea—brain cancer	2.24e-05	0.000386	CcSEcCtD
Doxorubicin—ABCB1—spinal cord—brain cancer	2.24e-05	0.000738	CbGeAlD
Doxorubicin—Anaphylactic shock—Etoposide—brain cancer	2.24e-05	0.000385	CcSEcCtD
Doxorubicin—Infection—Etoposide—brain cancer	2.22e-05	0.000383	CcSEcCtD
Doxorubicin—Urticaria—Temozolomide—brain cancer	2.22e-05	0.000382	CcSEcCtD
Doxorubicin—Abdominal pain—Temozolomide—brain cancer	2.21e-05	0.000381	CcSEcCtD
Doxorubicin—Body temperature increased—Temozolomide—brain cancer	2.21e-05	0.000381	CcSEcCtD
Doxorubicin—Thrombocytopenia—Etoposide—brain cancer	2.19e-05	0.000377	CcSEcCtD
Doxorubicin—Tachycardia—Etoposide—brain cancer	2.18e-05	0.000376	CcSEcCtD
Doxorubicin—Skin disorder—Etoposide—brain cancer	2.17e-05	0.000374	CcSEcCtD
Doxorubicin—Hyperhidrosis—Etoposide—brain cancer	2.16e-05	0.000372	CcSEcCtD
Doxorubicin—Anorexia—Etoposide—brain cancer	2.13e-05	0.000367	CcSEcCtD
Doxorubicin—Hypersensitivity—Carmustine—brain cancer	2.13e-05	0.000367	CcSEcCtD
Doxorubicin—Nausea—Hydroxyurea—brain cancer	2.13e-05	0.000366	CcSEcCtD
Doxorubicin—Hypotension—Etoposide—brain cancer	2.09e-05	0.00036	CcSEcCtD
Doxorubicin—Asthenia—Carmustine—brain cancer	2.08e-05	0.000357	CcSEcCtD
Doxorubicin—Hypersensitivity—Temozolomide—brain cancer	2.06e-05	0.000355	CcSEcCtD
Doxorubicin—ABCB1—endocrine gland—brain cancer	2.01e-05	0.000665	CbGeAlD
Doxorubicin—Paraesthesia—Etoposide—brain cancer	2.01e-05	0.000346	CcSEcCtD
Doxorubicin—Asthenia—Temozolomide—brain cancer	2.01e-05	0.000345	CcSEcCtD
Doxorubicin—CYP2D6—brain—brain cancer	2e-05	0.000661	CbGeAlD
Doxorubicin—Dyspnoea—Etoposide—brain cancer	1.99e-05	0.000343	CcSEcCtD
Doxorubicin—Somnolence—Etoposide—brain cancer	1.99e-05	0.000342	CcSEcCtD
Doxorubicin—ABCB1—head—brain cancer	1.99e-05	0.000656	CbGeAlD
Doxorubicin—Diarrhoea—Carmustine—brain cancer	1.98e-05	0.000341	CcSEcCtD
Doxorubicin—Pruritus—Temozolomide—brain cancer	1.98e-05	0.000341	CcSEcCtD
Doxorubicin—Decreased appetite—Etoposide—brain cancer	1.95e-05	0.000335	CcSEcCtD
Doxorubicin—Gastrointestinal disorder—Etoposide—brain cancer	1.93e-05	0.000333	CcSEcCtD
Doxorubicin—Fatigue—Etoposide—brain cancer	1.93e-05	0.000332	CcSEcCtD
Doxorubicin—Dizziness—Carmustine—brain cancer	1.91e-05	0.000329	CcSEcCtD
Doxorubicin—Pain—Etoposide—brain cancer	1.91e-05	0.000329	CcSEcCtD
Doxorubicin—Constipation—Etoposide—brain cancer	1.91e-05	0.000329	CcSEcCtD
Doxorubicin—Diarrhoea—Temozolomide—brain cancer	1.91e-05	0.000329	CcSEcCtD
Doxorubicin—Dizziness—Temozolomide—brain cancer	1.85e-05	0.000318	CcSEcCtD
Doxorubicin—Feeling abnormal—Etoposide—brain cancer	1.84e-05	0.000317	CcSEcCtD
Doxorubicin—Vomiting—Carmustine—brain cancer	1.84e-05	0.000317	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Etoposide—brain cancer	1.83e-05	0.000315	CcSEcCtD
Doxorubicin—Rash—Carmustine—brain cancer	1.82e-05	0.000314	CcSEcCtD
Doxorubicin—Dermatitis—Carmustine—brain cancer	1.82e-05	0.000314	CcSEcCtD
Doxorubicin—ABCB1—central nervous system—brain cancer	1.82e-05	0.000599	CbGeAlD
Doxorubicin—Headache—Carmustine—brain cancer	1.81e-05	0.000312	CcSEcCtD
Doxorubicin—Vomiting—Temozolomide—brain cancer	1.78e-05	0.000306	CcSEcCtD
Doxorubicin—Urticaria—Etoposide—brain cancer	1.78e-05	0.000306	CcSEcCtD
Doxorubicin—ABCB1—cerebellum—brain cancer	1.77e-05	0.000585	CbGeAlD
Doxorubicin—Body temperature increased—Etoposide—brain cancer	1.77e-05	0.000305	CcSEcCtD
Doxorubicin—Abdominal pain—Etoposide—brain cancer	1.77e-05	0.000305	CcSEcCtD
Doxorubicin—Rash—Temozolomide—brain cancer	1.76e-05	0.000304	CcSEcCtD
Doxorubicin—Dermatitis—Temozolomide—brain cancer	1.76e-05	0.000303	CcSEcCtD
Doxorubicin—Headache—Temozolomide—brain cancer	1.75e-05	0.000302	CcSEcCtD
Doxorubicin—Nausea—Carmustine—brain cancer	1.72e-05	0.000296	CcSEcCtD
Doxorubicin—Nausea—Temozolomide—brain cancer	1.66e-05	0.000286	CcSEcCtD
Doxorubicin—Hypersensitivity—Etoposide—brain cancer	1.65e-05	0.000284	CcSEcCtD
Doxorubicin—Asthenia—Etoposide—brain cancer	1.61e-05	0.000276	CcSEcCtD
Doxorubicin—Pruritus—Etoposide—brain cancer	1.58e-05	0.000273	CcSEcCtD
Doxorubicin—Diarrhoea—Etoposide—brain cancer	1.53e-05	0.000264	CcSEcCtD
Doxorubicin—Dizziness—Etoposide—brain cancer	1.48e-05	0.000255	CcSEcCtD
Doxorubicin—ABCB1—brain—brain cancer	1.44e-05	0.000475	CbGeAlD
Doxorubicin—Vomiting—Etoposide—brain cancer	1.42e-05	0.000245	CcSEcCtD
Doxorubicin—Rash—Etoposide—brain cancer	1.41e-05	0.000243	CcSEcCtD
Doxorubicin—Dermatitis—Etoposide—brain cancer	1.41e-05	0.000243	CcSEcCtD
Doxorubicin—Headache—Etoposide—brain cancer	1.4e-05	0.000241	CcSEcCtD
Doxorubicin—Nausea—Etoposide—brain cancer	1.33e-05	0.000229	CcSEcCtD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.69e-06	0.000267	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SUFU—brain cancer	8.68e-06	0.000267	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—PIK3CG—brain cancer	8.65e-06	0.000266	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—PIK3CG—brain cancer	8.65e-06	0.000266	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	8.65e-06	0.000266	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	8.64e-06	0.000266	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VAV1—brain cancer	8.63e-06	0.000265	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ABR—brain cancer	8.52e-06	0.000262	CbGpPWpGaD
Doxorubicin—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	8.49e-06	0.000261	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HES1—brain cancer	8.48e-06	0.000261	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—IDH1—brain cancer	8.46e-06	0.00026	CbGpPWpGaD
Doxorubicin—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	8.39e-06	0.000258	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GFAP—brain cancer	8.38e-06	0.000257	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	8.35e-06	0.000257	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GLI2—brain cancer	8.23e-06	0.000253	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—ENO2—brain cancer	8.21e-06	0.000252	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CDKN2A—brain cancer	8.17e-06	0.000251	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.16e-06	0.000251	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—CCND1—brain cancer	8.14e-06	0.00025	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—PIK3CG—brain cancer	8.13e-06	0.00025	CbGpPWpGaD
Doxorubicin—NOS1—Disease—PDGFRA—brain cancer	8.07e-06	0.000248	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8e-06	0.000246	CbGpPWpGaD
Doxorubicin—NOS3—Disease—SHH—brain cancer	7.99e-06	0.000246	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ENO2—brain cancer	7.99e-06	0.000246	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—BSG—brain cancer	7.98e-06	0.000245	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HEY1—brain cancer	7.94e-06	0.000244	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—ENO2—brain cancer	7.92e-06	0.000243	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.82e-06	0.00024	CbGpPWpGaD
Doxorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	7.82e-06	0.00024	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—DLL1—brain cancer	7.79e-06	0.000239	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GLI1—brain cancer	7.74e-06	0.000238	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—VEGFA—brain cancer	7.73e-06	0.000238	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—PCNA—brain cancer	7.73e-06	0.000238	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—BSG—brain cancer	7.65e-06	0.000235	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—PIK3CG—brain cancer	7.57e-06	0.000233	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	7.47e-06	0.00023	CbGpPWpGaD
Doxorubicin—NOS2—Disease—VAV1—brain cancer	7.43e-06	0.000228	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HES1—brain cancer	7.42e-06	0.000228	CbGpPWpGaD
Doxorubicin—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	7.39e-06	0.000227	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—ENO2—brain cancer	7.36e-06	0.000226	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SUFU—brain cancer	7.34e-06	0.000225	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—MYC—brain cancer	7.3e-06	0.000224	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN2A—brain cancer	7.3e-06	0.000224	CbGpPWpGaD
Doxorubicin—NOS1—Disease—IRS2—brain cancer	7.09e-06	0.000218	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GFAP—brain cancer	7.08e-06	0.000218	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PDGFRA—brain cancer	7.07e-06	0.000217	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—CYP2C9—brain cancer	7.05e-06	0.000217	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—PIK3CG—brain cancer	6.91e-06	0.000213	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—brain cancer	6.9e-06	0.000212	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—IDH1—brain cancer	6.87e-06	0.000211	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—SPP1—brain cancer	6.86e-06	0.000211	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—IL2—brain cancer	6.86e-06	0.000211	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	6.85e-06	0.000211	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—VAV1—brain cancer	6.83e-06	0.00021	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—IL2—brain cancer	6.82e-06	0.00021	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—CYP2C9—brain cancer	6.82e-06	0.00021	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	6.72e-06	0.000207	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HEY1—brain cancer	6.71e-06	0.000206	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	6.7e-06	0.000206	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—ENO2—brain cancer	6.69e-06	0.000206	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDK4—brain cancer	6.68e-06	0.000205	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	6.64e-06	0.000204	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SHH—brain cancer	6.62e-06	0.000204	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—IDH1—brain cancer	6.58e-06	0.000202	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—DLL1—brain cancer	6.58e-06	0.000202	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.57e-06	0.000202	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—MYC—brain cancer	6.53e-06	0.000201	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—PIK3CG—brain cancer	6.45e-06	0.000198	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HES1—brain cancer	6.39e-06	0.000197	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TRPC6—brain cancer	6.38e-06	0.000196	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—brain cancer	6.3e-06	0.000194	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PTCH1—brain cancer	6.28e-06	0.000193	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SMO—brain cancer	6.28e-06	0.000193	CbGpPWpGaD
Doxorubicin—NOS1—Disease—APC—brain cancer	6.26e-06	0.000192	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—CYP2C9—brain cancer	6.21e-06	0.000191	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IRS2—brain cancer	6.21e-06	0.000191	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	6.17e-06	0.00019	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CCND1—brain cancer	6.17e-06	0.00019	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IDH1—brain cancer	6.16e-06	0.000189	CbGpPWpGaD
Doxorubicin—NOS2—Disease—PDGFRA—brain cancer	6.09e-06	0.000187	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—BSG—brain cancer	6e-06	0.000184	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.88e-06	0.000181	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HES1—brain cancer	5.87e-06	0.000181	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—brain cancer	5.84e-06	0.00018	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HEY1—brain cancer	5.84e-06	0.000179	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—VEGFA—brain cancer	5.83e-06	0.000179	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—BSG—brain cancer	5.8e-06	0.000178	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—VEGFA—brain cancer	5.8e-06	0.000178	CbGpPWpGaD
Doxorubicin—NOS3—Disease—VAV1—brain cancer	5.77e-06	0.000177	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—DLL1—brain cancer	5.73e-06	0.000176	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	5.71e-06	0.000176	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SHH—brain cancer	5.59e-06	0.000172	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—PDGFRA—brain cancer	5.59e-06	0.000172	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.59e-06	0.000172	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—MYC—brain cancer	5.53e-06	0.00017	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—APC—brain cancer	5.48e-06	0.000168	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—PIK3CG—brain cancer	5.48e-06	0.000168	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—ENO2—brain cancer	5.43e-06	0.000167	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TRPC6—brain cancer	5.39e-06	0.000166	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—brain cancer	5.36e-06	0.000165	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.36e-06	0.000165	CbGpPWpGaD
Doxorubicin—NOS2—Disease—IRS2—brain cancer	5.34e-06	0.000164	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—IL2—brain cancer	5.33e-06	0.000164	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SMO—brain cancer	5.3e-06	0.000163	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PTCH1—brain cancer	5.3e-06	0.000163	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—BSG—brain cancer	5.28e-06	0.000162	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—ENO2—brain cancer	5.2e-06	0.00016	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—IDH1—brain cancer	5.16e-06	0.000159	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN2A—brain cancer	5.11e-06	0.000157	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	5.08e-06	0.000156	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NOTCH2—brain cancer	5.02e-06	0.000154	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—IDH1—brain cancer	4.99e-06	0.000153	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HES1—brain cancer	4.96e-06	0.000153	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MYC—brain cancer	4.95e-06	0.000152	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—IRS2—brain cancer	4.91e-06	0.000151	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ENO2—brain cancer	4.87e-06	0.00015	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—SHH—brain cancer	4.87e-06	0.00015	CbGpPWpGaD
Doxorubicin—NOS1—Disease—ERBB2—brain cancer	4.86e-06	0.000149	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	4.83e-06	0.000148	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.78e-06	0.000147	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VAV1—brain cancer	4.78e-06	0.000147	CbGpPWpGaD
Doxorubicin—NOS3—Disease—PDGFRA—brain cancer	4.73e-06	0.000145	CbGpPWpGaD
Doxorubicin—NOS2—Disease—APC—brain cancer	4.72e-06	0.000145	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—CYP2C9—brain cancer	4.55e-06	0.00014	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—IDH1—brain cancer	4.54e-06	0.000139	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—VEGFA—brain cancer	4.53e-06	0.000139	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—brain cancer	4.41e-06	0.000135	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—APC—brain cancer	4.34e-06	0.000133	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CCND1—brain cancer	4.31e-06	0.000133	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—RELA—brain cancer	4.28e-06	0.000132	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ERBB2—brain cancer	4.26e-06	0.000131	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CTNNB1—brain cancer	4.25e-06	0.000131	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NOTCH2—brain cancer	4.24e-06	0.00013	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.2e-06	0.000129	CbGpPWpGaD
Doxorubicin—NOS3—Disease—IRS2—brain cancer	4.15e-06	0.000128	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HES1—brain cancer	4.11e-06	0.000126	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—ENO2—brain cancer	4.08e-06	0.000125	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—brain cancer	4.06e-06	0.000125	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.06e-06	0.000125	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VAV1—brain cancer	4.04e-06	0.000124	CbGpPWpGaD
Doxorubicin—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.99e-06	0.000123	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—ENO2—brain cancer	3.94e-06	0.000121	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PDGFRA—brain cancer	3.92e-06	0.00012	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	3.87e-06	0.000119	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—BSG—brain cancer	3.87e-06	0.000119	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—IL2—brain cancer	3.86e-06	0.000119	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—SPP1—brain cancer	3.8e-06	0.000117	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—PIK3CG—brain cancer	3.76e-06	0.000116	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCND1—brain cancer	3.76e-06	0.000116	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CTNNB1—brain cancer	3.72e-06	0.000114	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.71e-06	0.000114	CbGpPWpGaD
Doxorubicin—NOS1—Disease—STAT3—brain cancer	3.71e-06	0.000114	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ERBB2—brain cancer	3.66e-06	0.000113	CbGpPWpGaD
Doxorubicin—NOS3—Disease—APC—brain cancer	3.66e-06	0.000113	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—PIK3CG—brain cancer	3.63e-06	0.000112	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—ENO2—brain cancer	3.59e-06	0.00011	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—VAV1—brain cancer	3.52e-06	0.000108	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HES1—brain cancer	3.48e-06	0.000107	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MYC—brain cancer	3.46e-06	0.000106	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MYC—brain cancer	3.44e-06	0.000106	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IRS2—brain cancer	3.44e-06	0.000106	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—brain cancer	3.42e-06	0.000105	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—PIK3CG—brain cancer	3.38e-06	0.000104	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EGFR—brain cancer	3.37e-06	0.000104	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ERBB2—brain cancer	3.37e-06	0.000104	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—CYP2C9—brain cancer	3.36e-06	0.000103	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—IDH1—brain cancer	3.33e-06	0.000102	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PDGFRA—brain cancer	3.31e-06	0.000102	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	3.28e-06	0.000101	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—VEGFA—brain cancer	3.28e-06	0.000101	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	3.25e-06	9.99e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—STAT3—brain cancer	3.25e-06	9.98e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—SPP1—brain cancer	3.21e-06	9.88e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CTNNB1—brain cancer	3.21e-06	9.86e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—CYP2C9—brain cancer	3.16e-06	9.72e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—PIK3CG—brain cancer	3.07e-06	9.43e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—PIK3CG—brain cancer	3.04e-06	9.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—APC—brain cancer	3.04e-06	9.34e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HES1—brain cancer	3.02e-06	9.3e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYC—brain cancer	3.02e-06	9.27e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EGFR—brain cancer	2.95e-06	9.07e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CTNNB1—brain cancer	2.95e-06	9.06e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IRS2—brain cancer	2.91e-06	8.93e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—PDGFRA—brain cancer	2.88e-06	8.85e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.86e-06	8.79e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—BSG—brain cancer	2.85e-06	8.77e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ERBB2—brain cancer	2.85e-06	8.75e-05	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—brain cancer	2.84e-06	8.74e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—STAT3—brain cancer	2.79e-06	8.59e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—BSG—brain cancer	2.69e-06	8.26e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.63e-06	8.09e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—ENO2—brain cancer	2.63e-06	8.08e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—brain cancer	2.6e-06	7.98e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.57e-06	7.91e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—STAT3—brain cancer	2.57e-06	7.89e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—APC—brain cancer	2.57e-06	7.89e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—PIK3CG—brain cancer	2.57e-06	7.89e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—brain cancer	2.54e-06	7.81e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—IRS2—brain cancer	2.53e-06	7.77e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CTNNB1—brain cancer	2.49e-06	7.65e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—PIK3CG—brain cancer	2.49e-06	7.65e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—brain cancer	2.48e-06	7.61e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—IDH1—brain cancer	2.45e-06	7.54e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—PIK3CG—brain cancer	2.39e-06	7.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—brain cancer	2.39e-06	7.34e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—RELA—brain cancer	2.37e-06	7.29e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB2—brain cancer	2.36e-06	7.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—brain cancer	2.33e-06	7.18e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—IDH1—brain cancer	2.31e-06	7.11e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—APC—brain cancer	2.23e-06	6.86e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—STAT3—brain cancer	2.17e-06	6.67e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	2.16e-06	6.65e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—IL2—brain cancer	2.14e-06	6.57e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCND1—brain cancer	2.08e-06	6.4e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—CYP2C9—brain cancer	2.07e-06	6.35e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CTNNB1—brain cancer	2.06e-06	6.34e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—brain cancer	2.02e-06	6.2e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—RELA—brain cancer	2.01e-06	6.16e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB2—brain cancer	1.99e-06	6.12e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—brain cancer	1.97e-06	6.06e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—ENO2—brain cancer	1.94e-06	5.96e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—PIK3CG—brain cancer	1.87e-06	5.75e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—ENO2—brain cancer	1.83e-06	5.62e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—VEGFA—brain cancer	1.82e-06	5.58e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—PIK3CG—brain cancer	1.81e-06	5.56e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—IL2—brain cancer	1.81e-06	5.55e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—STAT3—brain cancer	1.8e-06	5.53e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—brain cancer	1.76e-06	5.41e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—BSG—brain cancer	1.76e-06	5.4e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CTNNB1—brain cancer	1.74e-06	5.36e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB2—brain cancer	1.73e-06	5.33e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—brain cancer	1.67e-06	5.14e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—PIK3CG—brain cancer	1.65e-06	5.06e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—brain cancer	1.63e-06	5.02e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—VEGFA—brain cancer	1.53e-06	4.72e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—STAT3—brain cancer	1.52e-06	4.67e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CTNNB1—brain cancer	1.52e-06	4.66e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—IDH1—brain cancer	1.51e-06	4.65e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—brain cancer	1.41e-06	4.34e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—brain cancer	1.38e-06	4.25e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—brain cancer	1.37e-06	4.22e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—STAT3—brain cancer	1.32e-06	4.06e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—brain cancer	1.23e-06	3.78e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PIK3CG—brain cancer	1.21e-06	3.71e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—brain cancer	1.2e-06	3.69e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—ENO2—brain cancer	1.19e-06	3.67e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—brain cancer	1.16e-06	3.56e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PIK3CG—brain cancer	8.9e-07	2.73e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PIK3CG—brain cancer	8.38e-07	2.58e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PIK3CG—brain cancer	5.48e-07	1.68e-05	CbGpPWpGaD
